Form CORRESP - Correspondence:
SEC Accession No. 0001628280-23-042428
Filing Date
2023-12-21
Accepted
2023-12-21 13:41:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 9040
  Complete submission text file 0001628280-23-042428.txt   9973
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)